AAAAAA

   
Results: 1-3 |
Results: 3
The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination
Authors: Evans, TG Schiff, M Graves, B Agosti, J Barritt, ML Garner, D Holley, JL
Citation: Tg. Evans et al., The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination, CLIN NEPHR, 54(2), 2000, pp. 138-142
A randomized, double-blind, placebo-controlled trial of prophylactic recombinant human granulocyte-macrophage colony-stimulating factor to reduce nosocomial infections in very low birth weight neonates
Authors: Cairo, MS Agosti, J Ellis, R Laver, JJ Puppala, B deLemos, R Givner, L Nesin, M Wheeler, JG Seth, T van de Ven, C Fanaroff, A
Citation: Ms. Cairo et al., A randomized, double-blind, placebo-controlled trial of prophylactic recombinant human granulocyte-macrophage colony-stimulating factor to reduce nosocomial infections in very low birth weight neonates, J PEDIAT, 134(1), 1999, pp. 64-70
Anomalous origin of the left coronary artery from the pulmonary artery in adults. Long term follow up
Authors: de Salazar, AO Gonzalez, JA Zuazo, J Arzubiaga, J Agosti, J
Citation: Ao. De Salazar et al., Anomalous origin of the left coronary artery from the pulmonary artery in adults. Long term follow up, REV ESP CAR, 51(12), 1998, pp. 997-1001
Risultati: 1-3 |